NovaBay Pharmaceuticals Yönetim
Yönetim kriter kontrolleri 3/4
We currently do not have sufficient information about the CEO.
Anahtar bilgiler
Justin Hall
İcra Kurulu Başkanı
US$364.1k
Toplam tazminat
CEO maaş yüzdesi | 96.1% |
CEO görev süresi | 8.9yrs |
CEO sahipliği | 0.001% |
Yönetim ortalama görev süresi | Veri yok |
Yönetim Kurulu ortalama görev süresi | 4.1yrs |
Son yönetim güncellemeleri
CEO Tazminat Analizi
Tarih | Toplam Tazminat | Maaş | Şirket Kazançları |
---|---|---|---|
Jun 30 2024 | n/a | n/a | -US$17m |
Mar 31 2024 | n/a | n/a | -US$19m |
Dec 31 2023 | US$364k | US$350k | -US$17m |
Sep 30 2023 | n/a | n/a | -US$15m |
Jun 30 2023 | n/a | n/a | -US$19m |
Mar 31 2023 | n/a | n/a | -US$17m |
Dec 31 2022 | US$365k | US$350k | -US$16m |
Sep 30 2022 | n/a | n/a | -US$9m |
Jun 30 2022 | n/a | n/a | -US$5m |
Mar 31 2022 | n/a | n/a | -US$5m |
Dec 31 2021 | US$796k | US$329k | -US$7m |
Sep 30 2021 | n/a | n/a | -US$7m |
Jun 30 2021 | n/a | n/a | -US$8m |
Mar 31 2021 | n/a | n/a | -US$11m |
Dec 31 2020 | US$747k | US$286k | -US$11m |
Sep 30 2020 | n/a | n/a | -US$13m |
Jun 30 2020 | n/a | n/a | -US$10m |
Mar 31 2020 | n/a | n/a | -US$8m |
Dec 31 2019 | US$326k | US$260k | -US$10m |
Sep 30 2019 | n/a | n/a | -US$8m |
Jun 30 2019 | n/a | n/a | -US$10m |
Mar 31 2019 | n/a | n/a | -US$9m |
Dec 31 2018 | US$572k | US$260k | -US$7m |
Sep 30 2018 | n/a | n/a | -US$4m |
Jun 30 2018 | n/a | n/a | -US$5m |
Mar 31 2018 | n/a | n/a | -US$6m |
Dec 31 2017 | US$665k | US$228k | -US$7m |
Tazminat ve Piyasa: Justin's total compensation ($USD364.15K) is below average for companies of similar size in the US market ($USD655.65K).
Tazminat ve Kazançlar: Justin's compensation has been consistent with company performance over the past year.
CEO
Justin Hall (46 yo)
8.9yrs
Görev süresi
US$364,146
Tazminat
Mr. Justin M. Hall, Esq. has been General Counsel at NovaBay Pharmaceuticals, Inc. since December 2015, Corporate Secretary since July 16, 2017 and President and Chief Executive Officer since June 17, 2019...
Yönetim Kurulu Üyeleri
İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
---|---|---|---|---|
President | 4.3yrs | US$364.15k | 0.0014% $ 50.9 | |
Independent Chairman | 22.5yrs | US$78.08k | 0.0016% $ 57.9 | |
Independent Director | 5.2yrs | US$74.08k | 0.0015% $ 56.4 | |
Director | 8.8yrs | US$40.58k | 0.0015% $ 56.4 | |
Member of Ophthalmic Advisory Board | 9.1yrs | Veri yok | Veri yok | |
Independent Director | 4.9yrs | US$59.08k | 0.0015% $ 56.4 | |
Member of the Optometry Advisory Board | 4yrs | Veri yok | Veri yok | |
Member of the Ophthalmic Advisory Board | 4yrs | Veri yok | Veri yok | |
Member of the Ophthalmic Advisory Board | 4yrs | Veri yok | Veri yok | |
Member of the Ophthalmic Advisory Board | 4yrs | Veri yok | Veri yok | |
Member of the Ophthalmic Advisory Board | 4yrs | Veri yok | Veri yok | |
Member of the Ophthalmic Advisory Board | 4yrs | Veri yok | Veri yok |
4.1yrs
Ortalama Görev Süresi
50yo
Ortalama Yaş
Deneyimli Yönetim Kurulu: NBY's board of directors are considered experienced (4.1 years average tenure).